The Wendy's Company has adopted a limited-duration stockholder rights plan, commonly known as a "poison pill," in response to an unsolicited, non-binding acquisition proposal from an investor group led by Trian Fund Management, L.P. The Board of Directors rejected the proposal of $7.35 per share, stating it substantially undervalues the company.
Key Details
- Rights Plan: The plan is designed to deter hostile takeovers and will be triggered if any person or group acquires 15% or more of Wendy's common stock. It is set to expire on November 3, 2027.
- Rejected Proposal: The company rejected an unsolicited, non-binding proposal made on October 28, 2026, from an investor group to acquire all outstanding common stock for $7.35 per share.
- Related Actions: The company also amended its executive compensation and severance plans to update the definition of "Change in Control" and establish an 18-month protection period for severance and equity vesting following such an event.